Published in PLoS One on February 20, 2012
Peptide aptamers: development and applications. Curr Top Med Chem (2015) 0.80
Subunit disassembly and inhibition of TNFα by a semi-synthetic bicyclic peptide. Protein Eng Des Sel (2015) 0.79
Selection of specific protein binders for pre-defined targets from an optimized library of artificial helicoidal repeat proteins (alphaRep). PLoS One (2013) 0.77
Novel ubiquitin-derived high affinity binding proteins with tumor targeting properties. J Biol Chem (2014) 0.76
Specific targeting of the deubiquitinase and E3 ligase families with engineered ubiquitin variants. Bioeng Transl Med (2016) 0.75
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
Protein production by auto-induction in high density shaking cultures. Protein Expr Purif (2005) 29.74
NMR View: A computer program for the visualization and analysis of NMR data. J Biomol NMR (1994) 22.42
Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell (2009) 5.44
Ubiquitin-binding domains. Biochem J (2006) 5.32
Improved sensitivity of HSQC spectra of exchanging protons at short interscan delays using a new fast HSQC (FHSQC) detection scheme that avoids water saturation. J Magn Reson B (1995) 4.93
Solution structure of a CUE-ubiquitin complex reveals a conserved mode of ubiquitin binding. Cell (2003) 3.04
Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J Mol Biol (2003) 2.81
Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther (2002) 2.58
Molecular recognition in antibody-antigen complexes. Adv Protein Chem (2002) 2.33
Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat Biotechnol (1997) 2.21
Structure and ubiquitin binding of the ubiquitin-interacting motif. J Biol Chem (2003) 2.19
Folding and stability of a tryptophan-containing mutant of ubiquitin. Biochemistry (1993) 1.96
The active form of tumor necrosis factor is a trimer. J Biol Chem (1987) 1.86
Fast internal main-chain dynamics of human ubiquitin. Biochemistry (1992) 1.84
Small-molecule inhibition of TNF-alpha. Science (2005) 1.83
A designed ankyrin repeat protein evolved to picomolar affinity to Her2. J Mol Biol (2007) 1.71
Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target. Nat Methods (2007) 1.68
Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor. Clin Immunol (2009) 1.62
A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry (1990) 1.60
Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display. J Mol Biol (2008) 1.57
Circular dichroism studies of barnase and its mutants: characterization of the contribution of aromatic side chains. Biochemistry (1993) 1.53
Efficient protein selection based on ribosome display system with purified components. Biochem Biophys Res Commun (2006) 1.42
Anion binding to the ubiquitin molecule. Protein Sci (1998) 1.40
Assignment of the contribution of the tryptophan residues to the circular dichroism spectrum of human carbonic anhydrase II. Biochemistry (1994) 1.37
Characterization of the binding interface between ubiquitin and class I human ubiquitin-conjugating enzyme 2b by multidimensional heteronuclear NMR spectroscopy in solution. J Mol Biol (1999) 1.25
Artificial, non-antibody binding proteins for pharmaceutical and industrial applications. Trends Biotechnol (2005) 1.24
Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biotechnology (N Y) (1994) 1.11
Structure-activity studies of human tumour necrosis factors. Protein Eng (1994) 1.06
Iterative optimization of high-affinity proteases inhibitors using phage display. 1. Plasmin. Biochemistry (1996) 0.99
Structural and mechanistic insight into how antibodies inhibit serine proteases. Biochem J (2010) 0.98
Binding characteristics of tumor necrosis factor receptor-Fc fusion proteins vs anti-tumor necrosis factor mAbs. J Investig Dermatol Symp Proc (2007) 0.92
Homologous ELISA for detection of oligomeric human TNF: properties of the assay. J Immunol Methods (1995) 0.91
Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro. Biotechnol Appl Biochem (2009) 0.91
Small molecule inhibition of the TNF family cytokine CD40 ligand through a subunit fracture mechanism. ACS Chem Biol (2011) 0.90
Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach. Biophys Chem (2002) 0.87
Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein. J Mol Biol (2007) 0.86
Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha. Biochemistry (1995) 0.83
Kinetic analysis of TNF-alpha oligomer-monomer transition by surface plasmon resonance and immunochemical methods. Cytokine (1993) 0.83
High-affinity recognition of lanthanide(III) chelate complexes by a reprogrammed human lipocalin 2. J Am Chem Soc (2009) 0.81
Selection of a novel and highly specific tumor necrosis factor alpha (TNFalpha) antagonist: insight from the crystal structure of the antagonist-TNFalpha complex. J Biol Chem (2010) 0.80
Antigenic regions of tumor necrosis factor alpha and their topographic relationships with structural/functional domains. Mol Immunol (1992) 0.79
Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture. Protein Expr Purif (2010) 0.78
NMR studies on binding sites and aggregation-disassociation of fluorinated surfactant sodium perfluorooctanoate on protein ubiquitin. Biochim Biophys Acta (2008) 0.78
Comparison of reactivity of monoclonal antibody (3F2) to trimeric tumor necrosis factor (TNF-alpha) with that to monomeric TNF-alpha. J Biochem (1995) 0.76
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem (2008) 2.51
Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci U S A (2007) 2.13
Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes. Proc Natl Acad Sci U S A (2005) 2.01
Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. J Biol Chem (2009) 1.94
Passing the baton in class B GPCRs: peptide hormone activation via helix induction? Trends Biochem Sci (2009) 1.89
The redox-switch domain of Hsp33 functions as dual stress sensor. Nat Struct Mol Biol (2007) 1.69
Stimulation of poly(A) polymerase through a direct interaction with the nuclear poly(A) binding protein allosterically regulated by RNA. EMBO J (2003) 1.55
The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. EMBO Mol Med (2009) 1.53
Adaptor protein controlled oligomerization activates the AAA+ protein ClpC. EMBO J (2006) 1.49
Primary structure elements of spider dragline silks and their contribution to protein solubility. Biochemistry (2004) 1.48
Identification of a redox-regulated chaperone network. EMBO J (2003) 1.46
Inclusion bodies: formation and utilisation. Adv Biochem Eng Biotechnol (2004) 1.46
Prolyl isomerization as a molecular timer in phage infection. Nat Struct Mol Biol (2005) 1.41
Identification of residues in the human guanylate-binding protein 1 critical for nucleotide binding and cooperative GTP hydrolysis. J Mol Biol (2004) 1.35
Protein folding and stability of human CDK inhibitor p19(INK4d). J Mol Biol (2002) 1.25
Crystal structure of 12-oxophytodienoate reductase 3 from tomato: self-inhibition by dimerization. Proc Natl Acad Sci U S A (2006) 1.24
Structural insight into poly(A) binding and catalytic mechanism of human PARN. EMBO J (2005) 1.24
Artificial, non-antibody binding proteins for pharmaceutical and industrial applications. Trends Biotechnol (2005) 1.24
Activation of the redox-regulated chaperone Hsp33 by domain unfolding. J Biol Chem (2004) 1.23
Ganglioside-dependent cell attachment and endocytosis of murine polyomavirus-like particles. FEBS Lett (2003) 1.20
Interaction of trigger factor with the ribosome. J Mol Biol (2003) 1.19
The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1. J Biol Chem (2003) 1.19
YcdB from Escherichia coli reveals a novel class of Tat-dependently translocated hemoproteins. J Biol Chem (2006) 1.15
Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain. Biochemistry (2007) 1.14
Structure and dynamics of helix-0 of the N-BAR domain in lipid micelles and bilayers. Biophys J (2008) 1.10
Catalytic activity and chaperone function of human protein-disulfide isomerase are required for the efficient refolding of proinsulin. J Biol Chem (2001) 1.08
T-rich DNA single strands bind to a preformed site on the bacterial cold shock protein Bs-CspB. J Mol Biol (2006) 1.08
SlyD proteins from different species exhibit high prolyl isomerase and chaperone activities. Biochemistry (2006) 1.05
The Drosophila melanogaster Gene cg4930 Encodes a High Affinity Inhibitor for Endonuclease G. J Biol Chem (2009) 1.05
In vitro folding, functional characterization, and disulfide pattern of the extracellular domain of human GLP-1 receptor. Biophys Chem (2002) 1.03
Direct kinetic evidence for half-of-the-sites reactivity in the E1 component of the human pyruvate dehydrogenase multienzyme complex through alternating sites cofactor activation. Biochemistry (2006) 1.03
Killing of target cells by redirected granzyme B in the absence of perforin. FEBS Lett (2004) 0.99
The expression of heat shock protein 60 in myocardium of patients with chronic atrial fibrillation. Basic Res Cardiol (2002) 0.99
Biophysical characterization of refolded Drosophila Spätzle, a cystine knot protein, reveals distinct properties of three isoforms. J Biol Chem (2008) 0.99
NMR solution structure of SlyD from Escherichia coli: spatial separation of prolyl isomerase and chaperone function. J Mol Biol (2009) 0.98
Folding mechanism of an ankyrin repeat protein: scaffold and active site formation of human CDK inhibitor p19(INK4d). J Mol Biol (2007) 0.97
L-Arginine increases the solubility of unfolded species of hen egg white lysozyme. Protein Sci (2005) 0.97
Recognition of T-rich single-stranded DNA by the cold shock protein Bs-CspB in solution. Nucleic Acids Res (2006) 0.96
Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation. Protein Sci (2003) 0.95
Single-stranded DNA binding of the cold-shock protein CspB from Bacillus subtilis: NMR mapping and mutational characterization. Protein Sci (2003) 0.95
NMR spectroscopic characterization of millisecond protein folding by transverse relaxation dispersion measurements. J Am Chem Soc (2005) 0.94
Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody. J Mol Biol (2008) 0.94
Conformational switch upon phosphorylation: human CDK inhibitor p19INK4d between the native and partially folded state. ACS Chem Biol (2009) 0.94
RNA single strands bind to a conserved surface of the major cold shock protein in crystals and solution. RNA (2011) 0.94
Renaturation of human proinsulin--a study on refolding and conversion to insulin. Anal Biochem (2002) 0.93
Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs. J Mol Biol (2006) 0.93
Identification of a disulfide bridge essential for transport function of the human proton-coupled amino acid transporter hPAT1. J Biol Chem (2009) 0.92
Protein folding studied by real-time NMR spectroscopy. Methods (2004) 0.92
Molecular basis of β-amyloid oligomer recognition with a conformational antibody fragment. Proc Natl Acad Sci U S A (2012) 0.91
Combined NMR-observation of cold denaturation in supercooled water and heat denaturation enables accurate measurement of deltaC(p) of protein unfolding. Eur Biophys J (2005) 0.90
High yield production of recombinant native and modified peptides exemplified by ligands for G-protein coupled receptors. Protein Expr Purif (2008) 0.90
Structural basis for APPTPPPLPP peptide recognition by the FBP11WW1 domain. J Mol Biol (2005) 0.90
The prolyl isomerase domain of PpiD from Escherichia coli shows a parvulin fold but is devoid of catalytic activity. Protein Sci (2010) 0.89
Structural insights into an equilibrium folding intermediate of an archaeal ankyrin repeat protein. Proc Natl Acad Sci U S A (2008) 0.89
An old target revisited: two new privileged skeletons and an unexpected binding mode for HIV-protease inhibitors. Angew Chem Int Ed Engl (2005) 0.88
Biophysical comparison of BMP-2, ProBMP-2, and the free pro-peptide reveals stabilization of the pro-peptide by the mature growth factor. J Biol Chem (2005) 0.88
Crystal structure determination and functional characterization of the metallochaperone SlyD from Thermus thermophilus. J Mol Biol (2010) 0.88
Disulfide linkage and structure of highly stable yeast-derived virus-like particles of murine polyomavirus. J Biol Chem (2014) 0.88
Unexpected oligomeric structure of the FocA formate channel of Escherichia coli : a paradigm for the formate-nitrite transporter family of integral membrane proteins. FEMS Microbiol Lett (2009) 0.88
Suppression of protein aggregation by L-arginine. Curr Pharm Biotechnol (2009) 0.87
The unique hexokinase of Kluyveromyces lactis. Molecular and functional characterization and evaluation of a role in glucose signaling. J Biol Chem (2003) 0.87
The galactose switch in Kluyveromyces lactis depends on nuclear competition between Gal4 and Gal1 for Gal80 binding. J Biol Chem (2006) 0.87
Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension. Biochemistry (2008) 0.87
Recombinant expression, in vitro refolding, and biophysical characterization of the human glucagon-like peptide-1 receptor. Biochemistry (2010) 0.87
Listeriolysin O as cytotoxic component of an immunotoxin. Protein Sci (2009) 0.86
Affilin-novel binding molecules based on human gamma-B-crystallin, an all beta-sheet protein. J Mol Biol (2007) 0.86
Folding and association of an extremely stable dimeric protein from Sulfolobus islandicus. J Mol Biol (2004) 0.86
Mechanisms of activity and inhibition of the hepatitis C virus RNA-dependent RNA polymerase. J Biol Chem (2010) 0.86
Structural studies on a twin-arginine signal sequence. FEBS Lett (2003) 0.86
The mature part of proNGF induces the structure of its pro-peptide. FEBS Lett (2004) 0.85
The Cell Factory Aspergillus Enters the Big Data Era: Opportunities and Challenges for Optimising Product Formation. Adv Biochem Eng Biotechnol (2015) 0.85
Mammalian G-protein-coupled receptor expression in Escherichia coli: I. High-throughput large-scale production as inclusion bodies. Anal Biochem (2008) 0.85
Hexa-histidin tag position influences disulfide structure but not binding behavior of in vitro folded N-terminal domain of rat corticotropin-releasing factor receptor type 2a. Protein Sci (2004) 0.85
Ionic liquids as refolding additives: N'-alkyl and N'-(omega-hydroxyalkyl) N-methylimidazolium chlorides. Protein Sci (2005) 0.85
Intradomain disulfide bonds impede formation of the alternatively folded state of antibody chains. J Mol Biol (2002) 0.85
Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions. Biochemistry (2005) 0.85
A remote prolyl isomerization controls domain assembly via a hydrogen bonding network. Proc Natl Acad Sci U S A (2009) 0.85
Functional solubilization of aggregation-prone HIV envelope proteins by covalent fusion with chaperone modules. J Mol Biol (2004) 0.85
Mammalian G protein-coupled receptor expression in Escherichia coli: II. Refolding and biophysical characterization of mouse cannabinoid receptor 1 and human parathyroid hormone receptor 1. Anal Biochem (2010) 0.85
Identification and functional characterisation of genes and corresponding enzymes involved in carnitine metabolism of Proteus sp. Arch Microbiol (2005) 0.84
Oligomerization and assembly of the matrix protein of Borna disease virus. FEBS Lett (2005) 0.84
Characterization of a dipartite iron uptake system from uropathogenic Escherichia coli strain F11. J Biol Chem (2011) 0.84
Structure and function of a regulated archaeal triosephosphate isomerase adapted to high temperature. J Mol Biol (2004) 0.84
The pro-peptide of proNGF: structure formation and intramolecular association with NGF. Protein Sci (2007) 0.84